<DOC>
	<DOCNO>NCT02878707</DOCNO>
	<brief_summary>Dexmedetomidine ( DEX ) Alpha-2 specific agonist , common ICU sedation medication . In brain tumor resection craniotomy , proven effective improve postoperative hypertension tachycardia , mitigate postoperative nausea vomit relives postoperative pain . In addition , many animal experiment show DEX inhibits proapoptosis mitochondrial vivo therefore avoids neuronal injury . It also report neuroprotective isoflurane-induced neurotoxicity improve cerebral focal ischemic region ( penumbra ) . However , neuroprotective effect never investigate clinically patient undergo brain tumor resection surgery .</brief_summary>
	<brief_title>The Neuroprotective Effects Dexmedetomidine During Brain Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cerebrovascular Disorders</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Neuroprotective Agents</mesh_term>
	<criteria>Patients undergo elective craniotomy supratentorial brain tumor resection cerebral vascular surgery age 20 75 yr Evidence infectious condition , fever , elevate white blood cell Creactive protein Impaired liver function , eg . AST ALT &gt; 100 ; liver cirrhosis &gt; Child B class Impaired renal function , cGFR &lt; 60 ml/min/1.73 m2 Cardiac dysfunction , heart failure &gt; NYHA class II , coronary arterial disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>